![Matthew Foehr](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matthew Foehr
Amministratore Delegato presso
OMNIAB, INC.
Patrimonio netto: 16 M $ in data 31/05/2026
Profilo
Matthew William Foehr is President, Chief Executive Officer & Director at OmniAb Operations, Inc. and OmniAb, Inc. since 2022.
He serves as Director at Pelican, Inc. since 2020, Director at Ligand UK Group Ltd. since 2018, and Independent Director at Viking Therapeutics, Inc. since 2014.
Former roles include Independent Director at Ritter Pharmaceuticals, Inc. from 2015 to 2020; Director at Ligand UK Ltd. from 2018 to 2022; President & Chief Operating Officer at Ligand Pharmaceuticals, Inc. from 2015 to 2022; Senior Vice President-Technical Operations at Connetics Corp.
from 1999 to 2006; Senior VP-Global Research & Development Operations at Stiefel Laboratories, Inc. from 2009 to 2011; and Chief Scientific Officer-Dermatology & VP at GlaxoSmithKline LLC from 2010 to 2011.
Education includes undergraduate studies at Santa Clara University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
OMNIAB, INC. 3,05% | 23/04/2026 | 4.420.492 ( 3,05% ) | 12 M $ | 31/05/2026 |
| 15/03/2026 | 132.036 ( 0,11% ) | 4 M $ | 31/05/2026 |
Posizioni attive di Matthew Foehr
| Società | Posizione | Inizio |
|---|---|---|
| VIKING THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 01/05/2014 |
| PFENEX INC. | Direttore/Membro del Consiglio | 01/10/2020 |
| OMNIAB, INC. | Amministratore Delegato | 01/11/2022 |
Ligand UK Group Ltd.
 Ligand UK Group Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Direttore/Membro del Consiglio | 12/10/2018 |
OmniAb Operations, Inc.
 OmniAb Operations, Inc. BiotechnologyHealth Technology Develops drug discovery platform | Amministratore Delegato | 01/11/2022 |
Precedenti posizioni note di Matthew Foehr
| Società | Posizione | Fine |
|---|---|---|
Ligand UK Research Ltd.
 Ligand UK Research Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Direttore/Membro del Consiglio | 19/03/2024 |
| VERNALIS | Direttore/Membro del Consiglio | 01/11/2022 |
| LIGAND PHARMACEUTICALS INCORPORATED | Presidente | 01/01/2022 |
| AIXCRYPTO HOLDINGS, INC. | Direttore/Membro del Consiglio | 01/05/2020 |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Matthew Foehr
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
55
Relazioni di 1° grado
13
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 13 |
|---|---|
Ligand Pharmaceuticals, Inc.
 Ligand Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and sells drug development technologies | Health Technology |
Ligand UK Ltd.
 Ligand UK Ltd. BiotechnologyHealth Technology Engages in research and development & sells pharmaceutical products | Health Technology |
Connetics Corp.
 Connetics Corp. BiotechnologyHealth Technology Develops and commercializes dermatology products | Health Technology |
Ritter Pharmaceuticals, Inc.
 Ritter Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of therapeutic treatments for gastrointestinal diseases and conditions | Health Technology |
Ligand UK Research Ltd.
Ligand UK Research Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Santa Clara University
 Santa Clara University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stiefel Laboratories, Inc.
 Stiefel Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Health Technology |
Pelican Inc
 Pelican Inc Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical therapeutics and vaccines | Health Technology |
Ligand UK Group Ltd.
Ligand UK Group Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Viking Therapeutics, Inc.
 Viking Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for metabolic and endocrine disorders | Health Technology |
OmniAb Operations, Inc.
OmniAb Operations, Inc. BiotechnologyHealth Technology Develops drug discovery platform | Health Technology |
OmniAb, Inc.
 OmniAb, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Commercial Services |
